Skip to content

CARL CARL Payments For Deferred Initial Public Offering Costs

Payments For Deferred Initial Public Offering Costs at other companies

ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$149.75K
Altimmune logo
AltimmuneALT
$89K-28.8%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$700K
Rigetti Computing, Inc. logo
Rigetti Computing, Inc.RGTI
$0-100%
Navan, Inc.
 logo
Navan, Inc. NAVN
$407K
ALO
Aldabra 4 Liquidity Opportunity Vehicle ALOV
$99.48K

Other financials

Income statement

See full
Revenue$16.1M+58.2%
Gross profit$12.4M+62.7%
Operating income-$9.3M-62.2%
Net income-$8.7M-51.8%
EPS (diluted)-$0.32+78.2%

Balance sheet

See full
Cash & equivalents$73.0M+68.1%
Total debt$17.3M
Total equity$92.2M+220%
Total assets$118.8M

Cash flow

See full
Operating cash flow-$13.0M-59.5%
CapEx$79.0K-4.8%
Free cash flow-$13.1M-58.8%

Valuation

See full
Market cap$305.56M-20.3%
Enterprise value$249.8M
P/S5.4×

Profitability

See full
Gross margin75.9%+1.4pp
Operating margin-60.5%-10.2pp
Net margin-57.8%-11.2pp
FCF margin-61.1%

Returns & leverage

See full
Return on equity-416.9%
Debt / equity0.2×
Current ratio11.9×

Where this comes from

Reported directly by CARL in its filing.

Tagged under the XBRL concept carl:PaymentsForDeferredInitialPublicOfferingCosts.

The official record: CARL’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about CARL's payments for deferred initial public offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CARL's payments for deferred initial public offering costs?
CARL (CARL) reported payments for deferred initial public offering costs of $1.35M in Q4 2025.
What does payments for deferred initial public offering costs mean?
This captures the cash outflows incurred for professional fees, legal expenses, and underwriting costs directly related to the preparation and execution of an initial public offering. These costs are deferred and typically offset against the proceeds from the offering upon completion. Monitoring these payments helps evaluate the total cost of capital associated with accessing public equity markets.